These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 24579066

  • 1. Bis-indolic compounds as potential new therapeutic alternatives for tularaemia.
    Caspar Y, Sutera V, Boisset S, Denis JN, Maurin M.
    Front Cell Infect Microbiol; 2014; 4():24. PubMed ID: 24579066
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
    Caspar Y, Hennebique A, Maurin M.
    J Antimicrob Chemother; 2018 Mar 01; 73(3):687-691. PubMed ID: 29253157
    [Abstract] [Full Text] [Related]

  • 3. A new dye uptake assay to test the activity of antibiotics against intracellular Francisella tularensis.
    Sutera V, Caspar Y, Boisset S, Maurin M.
    Front Cell Infect Microbiol; 2014 Mar 01; 4():36. PubMed ID: 24672776
    [Abstract] [Full Text] [Related]

  • 4. Francisella tularensis Susceptibility to Antibiotics: A Comprehensive Review of the Data Obtained In vitro and in Animal Models.
    Caspar Y, Maurin M.
    Front Cell Infect Microbiol; 2017 Mar 01; 7():122. PubMed ID: 28443249
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility of isolates of Francisella tularensis from Turkey.
    Kiliç S, Celebi B, Acar B, Ataş M.
    Scand J Infect Dis; 2013 May 01; 45(5):337-41. PubMed ID: 23249114
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [In Vitro Activity of Tigecycline Against Francisella tularensis Subsp. holarctica in Comparison with Doxycycline, Ciprofloxacin and Aminoglycosides].
    Ulu Kılıç A, Kılıç S, Celebi B, Sencan I.
    Mikrobiyol Bul; 2013 Jan 01; 47(1):189-91. PubMed ID: 23390918
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New therapeutic approaches for treatment of tularaemia: a review.
    Boisset S, Caspar Y, Sutera V, Maurin M.
    Front Cell Infect Microbiol; 2014 Jan 01; 4():40. PubMed ID: 24734221
    [Abstract] [Full Text] [Related]

  • 13. Septic pneumonic tularaemia caused by Francisella tularensis subsp. holarctica biovar II.
    Fritzsch J, Splettstoesser WD.
    J Med Microbiol; 2010 Sep 01; 59(Pt 9):1123-1125. PubMed ID: 20522628
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. First isolation of Francisella tularensis subsp. tularensis in Europe.
    Gurycová D.
    Eur J Epidemiol; 1998 Dec 01; 14(8):797-802. PubMed ID: 9928875
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains.
    Tomaso H, Al Dahouk S, Hofer E, Splettstoesser WD, Treu TM, Dierich MP, Neubauer H.
    Int J Antimicrob Agents; 2005 Oct 01; 26(4):279-84. PubMed ID: 16143497
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genetic Diversity and Spatial Segregation of Francisella tularensis Subspecies holarctica in Germany.
    Appelt S, Köppen K, Radonić A, Drechsel O, Jacob D, Grunow R, Heuner K.
    Front Cell Infect Microbiol; 2019 Oct 01; 9():376. PubMed ID: 31781515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.